Response of 1,5-anhydroglucitol to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial

BACKGROUND: Low 1,5-anhydroglucitol (1,5-AG) is a marker of glycosuric hyperglycemia. We evaluated 1,5-AG with clinical outcomes and assessed the effects of glucose- and blood pressure-lowering interventions on change in 1,5-AG in type 2 diabetes. METHODS: We measured 1,5-AG in 6,826 stored samples...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Selvin, Elizabeth, Wang, Dan, McEvoy, John William, Juraschek, Stephen P., Lazo, Mariana, Hamet, Pavel, Cooper, Mark, Marre, Michel, Williams, Bryan, Harrap, Stephen, Chalmers, John, Woodward, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620118/
https://ncbi.nlm.nih.gov/pubmed/31050156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13755
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados